171 related articles for article (PubMed ID: 38685067)
1. Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistance.
Cui J; Liu X; Shang Q; Sun S; Chen S; Dong J; Zhu Y; Liu L; Xia Y; Wang Y; Xiang L; Fan B; Zhan J; Zhou Y; Chen P; Zhao R; Liu X; Xing N; Wu D; Shi B; Zou Y
Mol Cancer; 2024 Apr; 23(1):86. PubMed ID: 38685067
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitinase OTUD6A promotes proliferation of cancer cells via regulating Drp1 stability and mitochondrial fission.
Shi L; Liu J; Peng Y; Zhang J; Dai X; Zhang S; Wang Y; Liu J; Long J
Mol Oncol; 2020 Dec; 14(12):3169-3183. PubMed ID: 33070427
[TBL] [Abstract][Full Text] [Related]
3. Ovarian tumor deubiquitinase 6A regulates cell proliferation via deubiquitination of nucleolin and caspase‑7.
Kim SH; Baek KH
Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 36082810
[TBL] [Abstract][Full Text] [Related]
4. Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3.
Liu X; Fang Y; Lv X; Hu C; Chen G; Zhang L; Jin B; Huang L; Luo W; Liang G; Wang Y
Cell Death Differ; 2023 Jun; 30(6):1457-1471. PubMed ID: 36932155
[TBL] [Abstract][Full Text] [Related]
5. OTUD6A Is an Aurora Kinase A-Specific Deubiquitinase.
Kim HJ; Kim J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669244
[TBL] [Abstract][Full Text] [Related]
6. Deubiquitinase OTUD6a drives cardiac inflammation and hypertrophy by deubiquitination of STING.
Fang Z; Han J; Lin L; Ye B; Qu X; Zhang Y; Zhao Y; Xu D; Lin W; Shen S; Min J; Wu G; Huang Z; Liang G
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167061. PubMed ID: 38342418
[TBL] [Abstract][Full Text] [Related]
7. OTUD6A promotes prostate tumorigenesis via deubiquitinating Brg1 and AR.
Fu X; Zhao J; Yu G; Zhang X; Sun J; Li L; Yin J; Niu Y; Ren S; Zhu Y; Xu B; Huang L
Commun Biol; 2022 Mar; 5(1):182. PubMed ID: 35233061
[TBL] [Abstract][Full Text] [Related]
8. Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy.
Zhao Y; Huang X; Zhu D; Wei M; Luo J; Yu S; Tian Y; Zheng X
Cell Death Differ; 2022 Dec; 29(12):2531-2544. PubMed ID: 35768646
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific oncogene OTUD6A promotes prostatic tumorigenesis via deubiquitinating and stabilizing c-Myc.
Peng Y; Liu J; Wang Z; Cui C; Zhang T; Zhang S; Gao P; Hou Z; Liu H; Guo J; Zhang J; Wen Y; Wei W; Zhang L; Liu J; Long J
Cell Death Differ; 2022 Sep; 29(9):1730-1743. PubMed ID: 35217790
[TBL] [Abstract][Full Text] [Related]
10. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.
Jing C; Duan Y; Zhou M; Yue K; Zhuo S; Li X; Liu D; Ye B; Lai Q; Li L; Yao X; Wei H; Zhang W; Wu Y; Wang X
Theranostics; 2021; 11(6):2655-2669. PubMed ID: 33456565
[TBL] [Abstract][Full Text] [Related]
11. The RNA-Binding Protein HuR Confers Oxaliplatin Resistance of Colorectal Cancer By Upregulating CDC6.
Cai J; Wang H; Jiao X; Huang R; Qin Q; Zhang J; Chen H; Feng D; Tian X; Wang H
Mol Cancer Ther; 2019 Jul; 18(7):1243-1254. PubMed ID: 31064870
[TBL] [Abstract][Full Text] [Related]
12. ZNF143-Mediated H3K9 Trimethylation Upregulates CDC6 by Activating MDIG in Hepatocellular Carcinoma.
Zhang L; Huo Q; Ge C; Zhao F; Zhou Q; Chen X; Tian H; Chen T; Xie H; Cui Y; Yao M; Li H; Li J
Cancer Res; 2020 Jun; 80(12):2599-2611. PubMed ID: 32312832
[TBL] [Abstract][Full Text] [Related]
13. The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway.
Seo D; Jung SM; Park JS; Lee J; Ha J; Kim M; Park SH
EBioMedicine; 2019 Nov; 49():55-71. PubMed ID: 31685442
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-based genome-wide screening for deubiquitinase subfamily identifies USP1 regulating MAST1-driven cisplatin-resistance in cancer cells.
Tyagi A; Kaushal K; Chandrasekaran AP; Sarodaya N; Das S; Park CH; Hong SH; Kim KS; Ramakrishna S
Theranostics; 2022; 12(13):5949-5970. PubMed ID: 35966591
[No Abstract] [Full Text] [Related]
15. Ubiquitin-specific protease 2a promotes hepatocellular carcinoma progression via deubiquitination and stabilization of RAB1A.
Xiong B; Huang J; Liu Y; Zou M; Zhao Z; Gong J; Wu X; Qiu C
Cell Oncol (Dordr); 2021 Apr; 44(2):329-343. PubMed ID: 33074477
[TBL] [Abstract][Full Text] [Related]
16. OTUD5 promotes the growth of hepatocellular carcinoma by deubiquitinating and stabilizing SLC38A1.
Yang Y; Jia S; Zhu N; Xiao X; Ma Y; Tu K; Guo Y; Xu Q
Biol Direct; 2024 Apr; 19(1):31. PubMed ID: 38658981
[TBL] [Abstract][Full Text] [Related]
17. The deubiquitinase OTUD3 stabilizes ACTN4 to drive growth and metastasis of hepatocellular carcinoma.
Xie P; Chen Y; Zhang H; Zhou G; Chao Q; Wang J; Liu Y; Fang J; Xie J; Zhen J; Wang Z; Hao L; Huang D
Aging (Albany NY); 2021 Aug; 13(15):19317-19338. PubMed ID: 34380780
[TBL] [Abstract][Full Text] [Related]
18. Destabilization of CDC6 upon DNA damage is dependent on neddylation but independent of Cullin E3 ligases.
Tan CY; Hagen T
Int J Biochem Cell Biol; 2013 Jul; 45(7):1489-98. PubMed ID: 23597704
[TBL] [Abstract][Full Text] [Related]
19. OTUD6A in tubular epithelial cells mediates angiotensin II-induced kidney injury by targeting STAT3.
Sun X; Chen S; Zhao Y; Wu T; Zhao Z; Luo W; Han J; Fang Z; Ye B; Cao G; Huang S; Liang G
Am J Physiol Cell Physiol; 2024 Feb; 326(2):C400-C413. PubMed ID: 38105755
[TBL] [Abstract][Full Text] [Related]
20. RRM2 and CDC6 are novel effectors of XBP1-mediated endocrine resistance and predictive markers of tamoxifen sensitivity.
Barua D; Sultana A; Islam MN; Cox F; Gupta A; Gupta S
BMC Cancer; 2023 Mar; 23(1):288. PubMed ID: 36997866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
